Benzinga | Feb 4, 2021 04:32PM EST

T2 Biosystems Says Its T2SARS-CoV-2 Panel Is Capable Of Detecting Brazil Variant Of SARS-CoV-2

LEXINGTON, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2(tm) Panel--a molecular diagnostic test that detects SARS-CoV-2, the virus responsible for COVID-19 infections--is capable of detecting the Brazil (P.1) variant of the SARS-CoV-2 virus, which was recently confirmed to be present in the United States.